Gefitinib Completed Phase 2 Trials for Fallopian Tube Cancer / Primary Peritoneal Cavity Cancer / Cervical Cancers / Ovarian Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00049556Gefitinib in Treating Patients With Cervical Cancer
NCT00023699Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer